A Phase I/II Safety Study of DE-120 Injectable Solution for Age-related Macular Degeneration
Status:
Completed
Trial end date:
2016-04-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, bioactivity and
pharmacokinetics of three concentrations of DE-120 after a single intravitreal injection in
subjects with late stage exudative age-related macular degeneration.